HISTALOG Drug Patent Profile
✉ Email this page to a colleague
When do Histalog patents expire, and what generic alternatives are available?
Histalog is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in HISTALOG is betazole hydrochloride. Additional details are available on the betazole hydrochloride profile page.
Summary for HISTALOG
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 64 |
Patent Applications: | 34 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HISTALOG at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for HISTALOG
US Patents and Regulatory Information for HISTALOG
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | HISTALOG | betazole hydrochloride | INJECTABLE;INJECTION | 009344-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |